|

[ Download
MS Word Doc (111KB) ]
Contents

-
Introduction
1.1. This guideline is intended to complement the provisions of the
Medicines (Advertisement & Sale) Act 1956 (Revised – 1983) and the Medicine
Advertisement Board Regulation 1976.
1.2. Advertisements include any notice, circular, report, commentary,
pamphlet, label, wrapper or other document, and any announcement
made orally or by any means of producing or transmitting light or
sound.
-
Objective
2.1. The objective of this guideline is to ensure responsible advertising
in promoting the sale of medicines, appliances or remedies which
may be purchased by the public without prescription and for which
medical claims are made.
2.2. Advertisements to the general public should:
-
Help people to make
rational decisions on the use of medicines, appliances, remedies
determined to be legally available without a prescription;
-
Take into account of people’s legitimate
desire for information regarding their health.
-
Not take undue advantage
of people’s concern for their health.
-
Authority
3.1. The Medicine Advertisements Board (MAB) may, at its discretion,
issue or refuse to issue any approvals for advertisements to be publicized
or may cancel any approvals which were previously issued.
3.2. The Medicine Advertisements Board reserves the right to delete
from any advertisements, acts which could bring about undesirable
thoughts and impression to the viewers.
3.3. Changes to the Guidelines may be made from time to time by the
Medicine Advertisements Board without giving prior notice.
-
Prohibitions
4.1. Advertisements should not refer to any article or articles
in terms which are calculated to lead to the use of that article
or articles for the purpose of:-
-
Prevention, diagnosis
or treatment of the diseases and condition of human beings as
specified in the Schedule to The Medicines (Advertisement & Sale)
Act 1956 (Revised – 1983) ;
The list is reproduced as follows:-
- Diseases or defects of the kidney
- Diseases or defects of the
heart
- Diabetes
- Epilepsy or fits
- Paralysis
- Tuberculosis
- Asthma
- Leprosy
- Cancer
- Deafness
- Drug addiction
- Hernia or rupture
- Diseases of the eye
- Hypertension
- Mental
- Infertility
- Frigidity
- Impairment of the sexual function or impotency
- Venereal disease
- Nervous debility, or other complaint or infirmity,
arising from or relating to sexual intercours
-
Practicing contraception among human beings.
-
Improving the condition
or functioning of the human kidney or heart, or improving the
sexual function or sexual performance of human beings.
-
Procuring
the miscarriage of women.
4.2. No products which
are poisons or contain poisons as specified in the Poisons list set
out in the First Schedule to the Poisons Act 1952 (Revised 1989)
may be advertised.
-
Contents
of Advertisement
Advertisements should contain information that is reliable, accurate,
truthful, informative, balanced, up-to-date, capable of substantiation
and in good taste. They should not contain any misleading or unverifiable
or omissions likely to induce medically unjustifiable use or to give
rise to undue risks.
5.1. General Principles
5.1.1. Impressions of Professional Advice or
Endorsement
Advertisements should not:-
-
have any visual and/or audio presentation of doctors,
dentists pharmacists, scientists, nurses and other paramedics,
etc., which give the impression of professional or scientific advice,
recommendation or endorsement.
-
contain statements giving the impression of professional
of scientific advice, endorsement or recommendation made by associations
or persons who appear in the advertisements and who are presented
either directly or by implication, as being qualified to give such
advice, endorsement or recommendation.
5.1.2.
Standard of Morality or Decency
Advertisements should not contain statements or visual presentation
which is, or likely to be interpreted to be contrary or offensive to
the standard of morality or decency prevailing in the Malaysian society
or in any way defamatory or humiliating to any segment of the public.
5.1.3. Trust, Fear or Superstition
Advertisements should not:-
-
be so framed as
to abuse the trust of the consumer or exploit his lack of experience
or knowledge.
-
without justification
play on fear. Advertisements should not contain any statement
or illustration likely to induce fear on the part of the viewer
or listener that he is suffering, or may without diagnosis or
treatment suffer, or suffer more severely, form diseases or conditions
of the human body.
- play on superstition or exploit the superstitious. In this spirit,
words like magic, magic, miracle, miraculous, saintly heavenly, or
presentation of or reference to mythical object or supernatural beings
or powers should no t be allowed.
- directly or by implication exploit
the religious requirement/beliefs of any community.
5.1.4.
Acts of Violence or Illegal Activities
Advertisements should not contain anything, which might lead or lend
support to acts of violence, or criminal or illegal activity nor should
they appear to condone such acts or activities.
5.1.5. Dangerous Practices or Disregard for Safety
Advertisement should not, without justifiable reason, show or refer
to dangerous practices or manifest a disregard for safety. Special
care should be taken in advertisements directed towards or depicting
children or young people.
5.1.6. Disparagement (Discredit)
Advertisement should not:
-
contain any statement
which either expressly or by implication disparages either the
medical profession or the value of professional attention and
treatment or another product.
-
Discredit or unfairly attack other products, advertisers
or advertisements directly or by implications.
5.1.7.
Children or Young People
Advertisements addressed to children or young people, or likely to
be seen by them, should not contain anything, whether in illustration
or otherwise, which might result in harming them physically, mentally,
or morally, or which exploits their credulity, their lack of experience
or their natural sense of loyalty.
5.2. Misleading Statement
Advertisements should not contain any statement, or visual presentation
which, directly or by implication, omission, ambiguity or claim, is
likely to mislead the consumer about any product or advertiser, in
particular with regards to:
-
The trade description;
-
Official or other recognition of approval or certification
5.3. Substantiation
All descriptions, claims and comparisons which relate to matters of
objectively ascertainable facts should be capable of substantiation
and should be held ready for immediate production upon request to the
Medicine Advertisements Board.
5.4. Tests, Trials, Research
Reference expressly or by implication to test, trials, research and
the like may only be used if they are fully substantiated. References
to tests or trials conducted in a named hospital, clinic, institute,
laboratory or college or by named professional or official organization
is permissible only if authorized and approved by the authority of
the institution or organization concerned and found acceptable by the
Medicine Advertisements Board.
5.4.1. Advertisements
should not:
-
contain any medical
statement or reference to clinical or other trials or tests which
cannot be substantiated by authoritative evidence acceptable
by the Medicine Advertisements Board.
-
misuse research results or quotation from technical
and scientific literature or conference, workshop, seminar etc.
Statistics should not be so presented as to imply that they have
a greater validity than is the case. Scientific terms or scientific
jargons that are irrelevant should not be used to make claims that
appear to have a scientific basis that they do not possess.
5.5. Testimonials
"No advertisement for a product may include a testimonial:"
-
by a professional or scientific association, body
or organization.
- by a person well-known in public life, sport, entertainment, professional
or scientific bodies, associations, organizations etc.
5.6. Name
of Product or Brand Name
-
Advertisement of
a product with a name containing the term “Doctor” or “Dr.” is
not acceptable unless the product was marketed under the name
prior to 1st. July, 1977.
-
The name of a product
should not indicate or imply its effectiveness or superior quality.
- Advertisement of a product should not highlight the name of manufacturer
or foreign country of origin.
5.7. General Claims
5.7.1. Hyperbole
Hyperbole should not be used in Medicine Advertisements unless such
hyperbole is used to attract attention to the advertisement and is
not used or implied in the advertisement as a claim or inference to
the superiority or superlative status of the product advertised.
Advertisements should not:
-
contain a copy which
is exaggerated by reason of the improper use of words, phrases
or methods of presentation e.g. the use of the words Fabulous,
Fantastic, Superior, Extremely, Unique, Ideal etc.
-
contain any false claim, direct or indirect, that
a product is ‘natural, nature’s remedy’ or the
like.
-
lead consumers to
over-estimate the value of a product whether by exaggeration
or through unrealistic comparisons.
-
highlight the flavor or the attractiveness of
the article expressly or by implication.
5.7.2.
Use of Certain Words or Phrases
The uses of the following words or phrases in the advertisement of
a product are not acceptable.
- Safe, safely, safety
- Guarantee, Ensure
- Magic, magical, miracle, miraculous
- Remedy, cure
- No side effects
- No harmful effects
- No toxic or adverse effects
- 100% Natural / Herbal / Pure
- NEW [Can only be used in case of
changes in packing, container, logo, or flavour. All changes must
be approved by the Drug Control Authority (DCA).]
The Medicine Advertisements
Board reserves the right to disallow any other words or phrases which
in its opinion is misleading, improper or not factual.
5.8. Specific Claims
5.8.1. Sexual weakness,
Ageing, Loss of Virility
Advertisements should not suggest or imply that any product offered
will:
- promote sexual virility or be effective in treating sexual weakness,
lost of virility or habits associated with sexual excess or indulgence,
or any ailment, illness or disease associated with such habits.
- retard, control or treat premature
ageing or any other words or phrases to that effect.
- retard, control or reverse the process of ageing.
5.8.2.
Loss of Hair, Baldness etc.
No advertisement should contain any claim or implicating that:-
-
baldness
can be prevented or cured
-
hair loss
or thinning of the hair can be arrested or reversed or reduced
-
hair growth
can be stimulated or improved
5.8.3.
Control of Dandruff
Advertisements for a product or treatment offered for the control of
dandruff should not contain any claim or implication that the condition
can be permanently prevented. Nor should such advertisement contain
any exaggerated claim or implication as to its effectiveness.
5.8.4. Weight reduction/loss
Weight reduction/loss products advertisement is not allowed in television
media.
For any other media, these products advertisement is allowed as approved by the
Medicine Advertisements Board.
5.8.5. Vitamins
-
No advertisement
should state or imply that good health is likely to be endangered
solely because people do not supplement their diets with vitamins.
-
Advertisements should not contain any unqualified
claims that vitamins will give adequate protection against or treatment
of viral infections, or unqualified statement that the medical
profession supports such claims.
5.8.6.
Functional claims
Only allowed for the
claims and conditions of use as approved by Drug Control Authority
5.8.7. Diseases or Conditions of Human body
-
Only the indications
as approved by DCA are allowed.
-
b) All advertisements,
unless approved by the Medicine Advertisement Board should not
refer to any product which can be used to prevent, diagnose or
treat conditions of human body.
5.9. Special/Cautionary Statements
The Medicine Advertisement Board may require cautionary statements
to be included in the advertisement.
5.9.1. Advertisements of:
-
products containing
herbs or herbal material should include the following sentence:
"This is a herbal preparation"
-
products containing alcohol for its pharmacological
effect or as a solvent should state the percentage content of such
alcohol as follows:-
"This preparation contains X % alcohol"
Methanol or methyl alcohol should not be present in products to
be taken internally / orally.
-
products containing
substances of animal origin should state the source of such substances
by specifying the part or organ and the name of the relevant
animal.
-
products containing
specially formulated fat, soluble vitamins for use as supplements
should include the following cautionary statement:
"Excessive vitamin intake may be detrimental to your
health"
-
products containing
aspirin should include the following cautionary statement:
"Not to be taken by children below 16 years old"
-
products for the
relief of fever, cough and pain should include the following
statement
"If symptoms persist, please consult your doctor"
-
medical self-diagnostic appliances such as blood-pressure
measuring watch, etc should include the following statement:
"Please consult doctor for interpretation of the result"
- products for weight reduction / weight loss should include the
following statement:
"This is a traditional preparation. Should be taken with
a balanced diet and regular exercise"
5.10. Competition, Free Gift, Free Offer, Premium,
etc
5.10.1. Advertisements should not:
-
encourage, directly or indirectly, indiscriminate,
unnecessary or excessive use of products.
-
contain any reference, directly or indirectly
to any prize competition, free gift, free offer, premium, exchange
scheme or any other similar scheme.
-
offer or describe any product as free or available
free for trial as an incentive.
- contain any reference to the free offer of a product with the purchase
of a similar or other product.
5.11. Mail Order/Information by Correspondence
-
Mail order advertising for a medical product should
not be permitted.
-
Advertisements should not contain any offer to
diagnose, prevent or treat any diseases or conditions of the human
body or symptoms of ill-health by correspondence nor invite information
in order to advise on diagnosis, prevention or treatment by correspondence.
-
advertisements should not invite or induce viewers
and readers to obtain information about products for the diagnosis,
prevention or treatment by correspondence.
5.12. Direct Sale from Manufacturer, Wholesaler
or Representative
5.12.1. An advertisement that encourages direct sale of a medical
product to any individual from the manufacturer, wholesaler or representative
is not allowed.
5.12.2. Home or office visits for the advertisement of a medical product
is not allowed whether solicited, unsolicited or otherwise.
-
Others
6.1. Press release
(a) Allowed for launching of new chemical entities (NCE).
Allowed
once only in newspapers.
The launch can also be broadcasted. The
contents are as approved by the Medicine Advertisements Board.
(b) The contents for the press release of New Chemical Entity (NCE) are
- Indications as approved by Drug Control Authority (DCA)
- Cost per dose
- List of reference journals
(c) Criteria for NCE are:
- New drugs
- New combination of active pharmaceutical ingredients
- Available in Malaysia for the first time
- New indication(s) (Note: All products must be registered with
DCA)
(d) The following informations are not allowed:
- Reference to any medical practitioner endorsing or promoting
the product
- Superlative words/statements (eg: the first, the best, the only
one,etc)
(e) The validity period is 3 months from the date of Approval.
(f) The frequency of the press release shall be once only and release simultaneously
in all media.
6.2.
Advertorial
Advertorial for poison products is not allowed. Advertorial
for generic or active ingredients of OTC and traditional products are
allowed. No mention of product name, brand or proprietary name. Only
company name and logo is allowed.
6.3. Journal
References
Allowed only for advertisement in the form of leaflets,
pamphlets and brochures.
6.4. Product & pricing
advertisement
MAB approval is not required if the advertisement contains only
the picture and price of the products. It is mandatory to print the DCA
registration number of the products.
-
Review
The Board can review the guideline from time to time.
Note:
Reviewed and approved by the Medicine Advertisement Board
at the MAB 7/2007 meeting on 17th July 2007.This amended guidelines
takes effect on 1st August 2007.

[ Download DOC (78KB) ]
-
EXEMPTIONS
This guideline do not apply to the following:-
-
The current practice of information being circulated within the profession through medical journals and newsletter which are published by medical bodies.
-
The present arrangement where the Malaysian Medical Association and Malaysian Dental Association have been granted approval by the Honorable Minister of Health to publish advertisements.
-
GENERAL PRINCIPLES
-
The purpose of this guideline is to inform the public about the type and nature of health care services that are available to them. The information should however be general in nature without specific reference to the person/s directly involved in their profession.
-
The authenticity and the accuracy of the information imparted should be verifiable by the Medicine Advertisements Board. The public should not be misled into drawing false impressions of the ability or services offered by the private hospital/clinic/radiological clinic or/and medical laboratory.
-
The information provided shall be in strict compliance with these set guidelines.
-
The information can be published in any media which is based, registered and published or circulated in Malaysia, and approved by the Board. However announcement over the Radio, Television, Rediffusion or Cinema is prohibited. The use of billboards, banners and similar devices are also prohibited unless within the facility's compound/premise for a period not exceeding 1 month.
-
Information about advances in medical services and therapeutics is best conducted through the appropriate medical forums to avoid the risk of unbalanced and inaccurate reporting.
-
For opening ceremonies, the management is responsible to ensuring that there is no undue publicity of the skills of professionals providing services related to the event. A prior written approval from Medicine Advertisement Board must be obtained for the text of the announcement.
-
INFORMATION WHICH
MAY BE DISCLOSED IN THE ANNOUNCEMENT ARE AS FOLLOWS
-
General Information
-
Name and location
-
Telephone number
-
Hours of service
-
Types of accommodation
and facilities
-
Charges for the
various services and facilities
-
Professional Services
e.g. Surgical, Maternity, Accident & Emergency, Rehabilitation
etc.
Name, qualification and field of specialty (recognised by the Ministry of Health) of doctors are allowed to be listed for information purposes. Promotion of any individual practitioner is not allowed.
-
Facilities are also allowed to announce recognised certification received by the facility eg. ISO, hospital accreditation, national or international quality awards, initiative awards, etc but not over-emphasized.
-
INFORMATION WHICH
IS NOT PERMITTED
-
Comparison, either direct or implied between hospital, clinic, radiological clinic or medical laboratory is prohibited. The use of superlatives (e.g. "the best", “most advanced”, “the first”) in describing the available services or facilities are also not permitted.
-
For publication of brochures or pamphlets, there should be not be any over-emphasis on personal references to doctors associated with the hospital, clinic, radiological clinic or medical laboratory. Testimonials from patients shall not be published or printed.
-
MEDIA
-
Print Media
-
Lay Press (Newspapers)
-
Size: No restriction
-
Frequency: The announcement shall only be allowed on the commencement of a facility or change of address of practice. The approved information may be published for 3 consecutive days. If it should appear in separate papers, it should be on the same 3 consecutive days.
The announcement on new services available and the installation of new equipment at the hospital is allowed not more than twice a year.
-
Colours: No restriction
-
Photographs:
Permitted up to MyKad size only. Photo should not show the registered
medical practitioner conducting procedures on patients.
-
Logos: Allowed
-
Content: As approved
by the Medicine Advertisements Board
-
Change of telephone
Numbers : Allowed but the size shall be limited to 8cm x 5cm.
-
Other criteria allowed for advertisement in the newspaper are:
Thank you/ Congratulatory message, opening/ launching of a new wing/ branch/ department/ discipline/ facility/ equipment, accreditation, seminar announcement.
-
Yellow Pages and
other directories
-
Maximum size: Not exceeding one page
-
Frequency: Every edition
-
Colours: No restriction
-
Photographs: Permitted up to MyKad size only.
Photo should not show the registered medical practitioner conducting
procedures on patients.
-
Logos: Allowed
-
Content: As approved by the Medicine Advertisements
Board
-
Pamphlets and Brochures
-
Colours: No restriction
-
Photographs: Permitted up to MyKad size only.
Photo should not show the registered medical practitioner conducting
procedures on patients.
-
Logos: Allowed
-
Content: As approved by the Medicine Advertisements
Board
-
Location map: Permitted
-
Distribution: No restriction.
-
Professional Publications
Information may be disseminated in medical journals and
newsletters which are published by medical bodies for circulation
to doctors.
-
Maximum Size: Not exceeding one page
-
Frequency: No restriction
-
Colours: No restriction
-
Photographs: Permitted up to MyKad size only.
Photo should not show the registered medical practitioner conducting
procedures on patients.
-
Logos: Allowed
-
Content: As approved by the Medicine Advertisements
Board
-
Change of telephone number: Allowed but the
size shall be limited to 8cm x 5cm
-
Magazines/handbook
-
Colours: No restriction
-
Photographs: Permitted up to MyKad size only.
Photo should not show the registered Medical practitioner conducting
procedures on patients.
-
Location map: Permitted
-
Telephone/fax/E-mail: Permitted
-
Size: Not exceeding one page
-
Content: As approved by the Medicine Advertisements
Board
-
Distribution: No limit
- Advertisement can be published in appropriate magazine.
-
Displaying Board
-
Colours: No restriction
-
Logos: Allowed
-
Content: As approved by the Medicine Advertisements
Board
-
Location: Within the premises or outside front
wall of the premise
-
Website/homepage
-
Colours: No restriction
-
Photographs: Permitted up to MyKad size only.
Photo should not show the registered Medical practitioner conducting
procedures on patients.
-
Logos: Allowed
-
Content: As approved by the Medicine Advertisements
Board
- Information on Medical practitioner: Name. qualifications, job
title, tel. number, e-mail (if personal website email, the website
should approved by Medicines Advertisements Board)
-
Other Media
-
Colours: No restriction
- Photographs: Permitted up to MyKad size only. Photo should not
show the Registered Medical Practitioner conducting procedures on
patients.
- Logos: Allowed
- Content: As approved by the Medicine
Advertisements Board
- Distribution: As approved by the
Medicine Advertisements Board
- Information on Medical practitioner:
Name. qualifications, job title, tel. number, e-mail
-
Radio & television
-
Radio: Not permitted
- Television: Video shows shown within that hospital premise or
aired in the hotels only. Contents as approved by the Medicine Advertisements
Board.
- OTHERS
- Congratulatory messages:
Contents as approved by the Medicine Advertisements Board.
- Agreement with insurance/
Credit card companies: Contents as approved by the Medicine Advertisements
Board.
- Other public announcements:
Contents as approved by the Medicine Advertisements Board.
- Lectures to lay
public: Title, date, venue, time, speakers' name and work place,
speakers picture (MyKad size only), contact person / number for
any queries
- REVIEW
The guideline may be reviewed as and when necessary.

Note: Approved by the
Medicine Advertisements Board - Meeting Bil 12/2007 dated 18th December 2007 and takes effect on 1st January 2008.
Acknowledgements: This guideline is a review of the October 1998 (first
revision) guidelines. The Medicine Advertisements Board is grateful to
the Association of Private Hospitals of Malaysia (APHM) for their contributions
in this guideline.
Na/ami/hd - garispanduan Lembaga Iklan Ubat
|
|